Skip to Main Content

Good morning, everyone, and how are you today? We are doing just fine, thank you, despite the cloudy skies looming over the Pharmalot campus. After all, the birds are still chirping and a pleasant breeze is wafting by. So this calls for a cup or three of stimulation. Remember, no prescription is required. Our choice today is bananas Foster. Yes, this is a real thing. Meanwhile, here are a few items of interest. Have a grand day, and drop us a line if you hear something saucy. …

Ending the latest chapter in a years-long legal battle over who invented CRISPR, the U.S. Patent and Trademark Office ruled that the revolutionary genome editing technology belongs to the Broad Institute of Harvard and MIT, STAT explains. The decision is a blow to the University of California and biotech companies that had licensed the technology from the university for use in developing treatments, including Intellia Therapeutics (NTLA) and CRISPR Therapeutics (CRSP). They will now have to negotiate with the Broad Institute for the right to use CRISPR for human therapies.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Create a display name to comment

This name will appear with your comment